Brief: Investor Group Issues Letter To Sesen Bio’s Board

Carisma Therapeutics

05/01/2023 14:08

Jan 5 (Reuters) - Sesen Bio Inc  SESN.O :
    * INVESTOR GROUP ISSUES LETTER TO SESEN BIO’S BOARD OF
DIRECTORS
REGARDING INTENT TO VOTE AGAINST PROPOSED CARISMA MERGER
    * LONGACRE SQUARE PARTNERS: BRADLEY L. RADOFF AND MICHAEL
TORO
TOGETHER WITH AFFILIATES REMAIN OPPOSED TO SESEN BIO'S PROPOSED
MERGER WITH CARISMA

Source text for Eikon:  ID:nBw2BSXrNa 
Further company coverage:  SESN.O 
 ((Reuters.Briefs@thomsonreuters.com;))